Morte, Adelaida; Vaqué, Anna; Iniesta, Marc; Schug, Barbara; Koch, Cornelius; Torre Fornell, Rafael de la; Schurad, Bjoern(Springer, 2022)
Background and objectives: rivastigmine is a reversible cholinesterase inhibitor indicated for the treatment of all stages of Alzheimer's disease (AD). Transdermal patch formulation allows smooth and continuous drug delivery. ...
Schurad, Bjoern; Koch, Cornelius; Schug, Barbara; Morte, Adelaida; Vaqué, Anna; Torre Fornell, Rafael de la; Iniesta, Marc(Bentham Science Publishers, 2022)
Background: Rivastigmine, a reversible AChEI for symptomatic treatment of mild to moderately severe Alzheimer's dementia, is administered once daily transdermal patches, enabling an easier and continuous drug delivery. A ...
